Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37826 - 37850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	MGST2	4258	upregulated	entinostat results in increased expression of MGST2 mRNA	4q31.1	A21037
Entinostat	Investigational	MIA	8190	upregulated	entinostat results in increased expression of MIA mRNA	19q13.2	A21035
Entinostat	Investigational	MIAT	440823	downregulated	entinostat results in decreased expression of MIAT mRNA	22q12.1	A21037
Entinostat	Investigational	MICA	100507436	upregulated	entinostat results in increased expression of MICA mRNA	6p21.33	A21035
Entinostat	Investigational	MICALCL	84953	upregulated	entinostat results in increased expression of MICALCL mRNA	11p15.3	A21037
Entinostat	Investigational	MICB	4277	upregulated	entinostat results in increased expression of MICB mRNA	6p21.33	A21037 A21035
Entinostat	Investigational	MID1IP1	58526	upregulated	entinostat results in increased expression of MID1IP1 mRNA	Xp11.4	A21037
Entinostat	Investigational	MIR124-2HG	100130155	downregulated	entinostat results in decreased expression of MIR124-2HG mRNA	8q12.3	A21037 A21035
Entinostat	Investigational	MIR31HG	554202	upregulated	entinostat results in increased expression of MIR31HG mRNA	9p21.3	A21035
Entinostat	Investigational	MIS18A	54069	downregulated	entinostat results in decreased expression of MIS18A mRNA	21q22.11	A21035
Entinostat	Investigational	MITF	4286	upregulated	entinostat results in increased expression of MITF mRNA	3p13	A21037
Entinostat	Investigational	MKL1	57591	downregulated	entinostat results in decreased expression of MKL1 mRNA	22q13.1-q13.2	A21035
Entinostat	Investigational	MLKL	197259	upregulated	entinostat results in increased expression of MLKL mRNA	16q22.3	A21037
Entinostat	Investigational	MLXIPL	51085	upregulated	entinostat results in increased expression of MLXIPL mRNA	7q11.23	A21037
Entinostat	Investigational	MMAA	166785	downregulated	entinostat results in decreased expression of MMAA mRNA	4q31.21	A21037
Entinostat	Investigational	MME	4311	upregulated	entinostat results in increased expression of MME mRNA	3q25.2	A21037 A21035
Entinostat	Investigational	MMP16	4325	downregulated	entinostat results in decreased expression of MMP16 mRNA	8q21.3	A21037 A21035
Entinostat	Investigational	MMP25	64386	upregulated	entinostat results in increased expression of MMP25 mRNA	16p13.3	A21037
Entinostat	Investigational	MMP9	4318	upregulated	entinostat results in increased expression of MMP9 mRNA	20q13.12	A21035
Entinostat	Investigational	MNS1	55329	upregulated	entinostat results in increased expression of MNS1 mRNA	15q21.3	A21037
Entinostat	Investigational	MOB3B	79817	downregulated	entinostat results in decreased expression of MOB3B mRNA	9p21.2	A21037
Entinostat	Investigational	MOCOS	55034	upregulated	entinostat results in increased expression of MOCOS mRNA	18q12.2	A21037
Entinostat	Investigational	MORF4L2	9643	upregulated	entinostat results in increased expression of MORF4L2 mRNA	Xq22.2	A21035
Entinostat	Investigational	MORN5	254956	upregulated	entinostat results in increased expression of MORN5 mRNA	9q33.2	A21035
Entinostat	Investigational	MPDU1	9526	downregulated	entinostat results in decreased expression of MPDU1 mRNA	17p13.1	A21035

Displaying entries 37826 - 37850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability